👀🥳🌟A new cooperation between @surgery_ai and @Orsi_Innotech SURGERY AI DAY https://t.co/6tPepgpKvo AIS will accept any form of submission for the conference, and will provide a professional editorial team to review the manuscript. You can register here: https://t.co/FaCuwkHZjb

In 2021 gender-based discrimination affects women surgeons from training to career progression often becoming a visible barrier to reach leadership positions. Women in Surgery Meets AIS Journal! https://t.co/xpl1qyG9Gh

👀 The current use of artificial intelligence in testicular cancer: a systematic review 😊 https://t.co/Oww0mYsEtW 👇👇👇

🥳🥳🥳Congratulations to Prof Andrew! 😊well deserved!

👉 Your guidance is welcome! 👈 📌 Utilization of telemedicine platforms has increased dramatically in Asia, but there are significant regional variations. 📌 Improving access, efficiency, and quality of global healthcare through telesurgical innovation can benefit humanity.

😉 The new article is online! 🌟 The current use of artificial intelligence in testicular cancer: a systematic review 🌟 https://t.co/IoXIRiQk1c 👏Welcome to communicate!👋

🤔Will telesurgery be popularized?

Looking forward to Prof. Ogiso’s Special issue “Revolutionizing Liver Surgery with AI: Innovations and Challenges in Liver Transplantation” is now online. Please find the call for papers here : https://t.co/5bk13RmneQ #artificialintelligencesurgery @surgery_ai

💟 Less blood loss and faster recovery time are the pursuit of numerous surgical experts! Ai-assisted surgery brings a whole different direction to minimally invasive surgery. ​ 📣You are welcome to submit your work in the special issue led by Prof. Sharona Ross.

👋Welcome to submit your paper here! 😊ORSI INNOTECH SURGICAL AI DAY DECEMBER 14-15, Orsi Academy, Ghent, Belgium 👏Come and find us to submit to https://t.co/1Tsama8U99 😎Also, here you can register for SURGICAL DAY: https://t.co/FaCuwkHZjb

ELSA2023, ISTANBUL Congress completed in great success.   The 16th Asia Pacific Congress of Endoscopic Laparoscopic Surgeons of Asia took place in Istanbul on 4th to 8th of October 2023 and was completed in great success. The congress commenced with courses on Laparoscopic

Machine learning (ML), which involves the use of computer-derived algorithms and systems to enhance knowledge to facilitate decision making, may be of great benefit to surgical patients. https://t.co/HBEPTlAL0o

📣 Dive into a World of Knowledge and Entertainment! 🌟 AIS Podcast: Episode 32: Interview of Michel Gagner, hosted by @andrew_gumbsMD. 👉 https://t.co/KkUrOVBKal 🔊 Subscribe, share, and let the journey begin! 🚀

🤩Artificial Intelligence Surgery (AIS) is an international peer-reviewed, open access, online journal.🤩 https://t.co/vS89ZfMlK5 The intended research fields of the journal include general surgery, surgical oncology and other surgical procedures. We look forward to your support.

The Mantra Surgical Robot: designed by the World’s premiere robotic cardiothoracic surgeon, Dr. Sudhir Srivastava, I’m proud to be join their Advisory Board as their first Hepatobiliary Surgeon. Better ergonomics, greener and not over-priced. Finally robotics for the entire World

👉New idea published👈. This article discusses the use of AI in colorectal cancer detection, with a particular focus on malignant polyps. This provides a scientific support for the AI-assisted diagnosis of diseases. 👉 https://t.co/t1hukWeRn9   Welcome to your discussion!🥳

⏰ Submit your AI research before Nov. 15 https://t.co/QJoEu7Ymzo 📘 Get published in the special issue of @surgery_ai Journal 🗣 Present your work at the 1st Surgical AI Day in Dec. at @orsiacademy 🏆 Eligible for Best Abstract Award! Register https://t.co/7aBWTVm8mX

Please keep ypu eyes on this！

🥳🥳🥳Happy to announce the Volume 3, Issue 3 of Artificial Intelligence Surgery is officially released today!!! 🌟🌟🌟Here you can check the 7 articles for this issue: https://t.co/p2t57U7F9x #surgomics #artificialintelligence #surgery

The #AiRGOS Project Combines: #Radiomics + #Genomics + #Oncopathology + #Surgiomics to provide clinicians with treatment guidelines for each individual tumor based on real world patient outcomes data. https://t.co/xKeDy20RbX